Prevent Blindness Seeks Applications for Joanne Angle Investigator Award Research Grant


Joanne Angle.

CHICAGO— Prevent Blindness is seeking applications for its 2014 Joanne Angle Investigator Award, a research grant provided annually to a project investigating public health related to eye health and safety. Grants are for a one-year period, up to $30,000, reviewed by a panel of scientists, and commence on July 1, 2014. Applications will be accepted in the following priority areas in adult vision, children's vision or eye injury—burden/economic aspects of eye disease/vision loss on society, best practices to integrate vision screening/follow-up care to system care access, and vision program effectiveness/evaluation. The deadline to submit applications is March 31, 2014.

“Supporting eye and vision research today is crucial to finding the answers to blinding eye diseases and conditions,” said Hugh R. Parry, president and CEO of Prevent Blindness. “By starting the next decade of this sight-saving program, we can help to make a real difference in the lives of those who have, or potentially could have, significant vision loss. By renaming this initiative as the Joanne Angle Investigator Award, we honor Ms. Angle’s legacy as a pioneer and leader in this important field.”

Angle, who passed away in March 2012, served with the Association for Research in Vision and Ophthalmology, from 1990 to 2012. She also served on the national board of directors for Prevent Blindness as well as on its government affairs and audit committees. Recently renamed the 2014 Joanne Angle Investigator Award to honor her work and dedication, the program has awarded more than $1 million to eye and vision research projects since its inception in 2003.

The 2013 Investigator Award went to Lyne Racette, PhD, assistant professor at the Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology at Indiana University in Indianapolis, Ind., for her study, “The effectiveness of motivational interviewing to improve adherence to glaucoma treatment in patients of African descent.” For more information or to submit an application, visit or call (800) 331-2020.